Prof. Anna Pannaccione | Biomedical | Best Researcher Award

Prof. Anna Pannaccione | Biomedical | Best Researcher Award

Professor at Federico II University of Naples, Italy

Profiles

Scopus

Orcid

Summary:

Prof. Anna Pannaccione has been an Associate Professor in Pharmacology since 2019, specializing in neurodegeneration research, particularly in Alzheimer’s Disease (AD) and Parkinson’s Disease (PD). Her work focuses on the dysregulation of ionic homeostasis, especially ion channels and exchangers, employing electrophysiological techniques. With 68 peer-reviewed publications and three patents, she is actively engaged in multidisciplinary research collaborations both nationally and internationally.

Education

Prof. Pannaccione completed her doctoral studies in Pharmacology, focusing on the molecular mechanisms underlying neurodegenerative diseases.

💼 Professional Experience

Prof. Pannaccione’s academic career is dedicated to discovering innovative therapies for neurodegenerative diseases like AD and PD. Her research emphasizes modulating Kv3.4 function, with the goal of developing therapeutic strategies to address energy failure and firing instability in neurodegenerative conditions.

🔬 Research Interests

Her research encompasses life sciences, focusing on neurological and neurodegenerative disorders, and the repair and regeneration of the nervous system. She is also a member of various research commissions, including SINS, SIF, and SfN, and serves as a referee for numerous international peer-reviewed journals.

 

Publications

Ultrafine particulate matter pollution and dysfunction of endoplasmic reticulum Ca2+ store: A pathomechanism shared with amyotrophic lateral sclerosis motor neurons?

  • Authors: Sapienza, S., Tedeschi, V., Apicella, B., Loffredo, S., Secondo, A.
  • Journal: Ecotoxicology and Environmental Safety
  • Year: 2024
  • Authors: Cantone, A.F., Burgaletto, C., Di Benedetto, G., Bernardini, R., Cantarella, G.
  • Journal: Cells
  • Year: 2024

Expanding Structure-Activity Relationships of Human Urotensin II Peptide Analogues: A Proposed Key Role of the N-Terminal Region for Novel Urotensin II Receptor Modulators

  • Authors: Merlino, F., Secondo, A., Mitidieri, E., d’Emmanuele di Villa Bianca, R., Carotenuto, A.
  • Journal: Journal of Medicinal Chemistry
  • Year: 2024

The 3-(3-oxoisoindolin-1-yl)pentane-2,4-dione (ISOAC1) as a new molecule able to inhibit Amyloid β aggregation and neurotoxicity

  • Authors: Piccialli, I., Greco, F., Roviello, G., Massa, A., Pannaccione, A.
  • Journal: Biomedicine and Pharmacotherapy
  • Year: 2023

Na+/Ca2+ exchanger isoform 1 takes part to the Ca2+-related prosurvival pathway of SOD1 in primary motor neurons exposed to beta-methylamino-l-alanine

  • Authors: Petrozziello, T., Boscia, F., Tedeschi, V., Annunziato, L., Secondo, A.
  • Journal: Cell Communication and Signaling
  • Year: 2022